Neuronal nicotinic acetylcholine receptors: From the gene to the disease

Behavioural Brain Research

Volumn 113, Issue 1-2, 2000, Pages 43-56

  Weiland, S ^a   Bertrand, D ^a   Leonard, S ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Acetylcholine; Disease; Gene; Neurone; Neurotransmission; Nicotinic

Indexed keywords

NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOMAL LOCALIZATION; EPILEPSY; FRONTAL LOBE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HUMAN; NEUROTRANSMISSION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SCHIZOPHRENIA; SLEEP WAKING CYCLE;

ALLELES; ANIMALS; BRAIN DISEASES; GENE FREQUENCY; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, NICOTINIC;

EID: 0033837262     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00199-6     Document Type: Article

References (139)

1. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry. 150:1993;1856-1861.
2. Adler L.E., Hoffer L.J., Griffith J., Waldo M.C., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiatry. 32:1992;607-616.
3. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 24:1998;189-202.
4. Adler L.E., Rose G., Freedman R. Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol. Biol. Psychiatry. 21:1986;787-798.
5. Agulhon C., Abitbol M., Bertrand D., Malafosse A. Localization of mRNA for CHRNA7 in human fetal brain. Neuroreport. 10:1999;2223-2227. [in process citation].
6. Agulhon C., Charnay Y., Vallet P., Abitbol M., Kobetz A., Bertrand D., Malafosse A. Distribution of mRNA for the alpha4 subunit of the nicotinic acetylcholine receptor in the human fetal brain. Brain Res. Mol. Brain Res. 1998:58;123-131. [published erratum appears in Brain Res Mol Brain Res 1999;63(2):384].
7. Akabas M.H., Kaufmann C., Archdeacon P., Karlin A. Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the alpha subunit. Neuron. 13:1994;919-927.
8. Akbarian S., Bunney W.E. Jr, Potkin S.G., Wigal S.B., Hagman J.O., Sandman C.A., Jones E.G. Altered distribution of nicotinamide-adenine dinucleotide phosphate- diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry. 50:1993;169-177.
9. Albuquerque E.X., Pereira E.F., Castro N.G., Alkondon M., Reinhardt S., Schroder H., Maelicke A. Nicotinic receptor function in the mammalian central nervous system. Ann. N. Y. Acad. Sci. 757:1995;48-72.
10. Anand R., Lindstrom J. Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. Genomics. 13:1992;962-967.
11. Barajas-Lopez C., Espinosa-Luna R., Zhu Y. Functional interactions between nicotinic and P2X channels in short- term cultures of guinea-pig submucosal neurons. J. Physiol. (Lond.). 513:1998;671-683. [see comments].
12. Belcher G., Ryall R.W. Substance P and Renshaw cells: a new concept of inhibitory synaptic interactions. J. Physiol. (Lond.). 272:1977;105-119.
13. Berger F., Gage F.H., Vijayaraghavan S. Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells. J. Neurosci. 18:1998;6871-6881.
14. Berkovic S.F., Howell R.A., Hay D.A., Hopper J.L. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann. Neurol. 43:1998;435-445.
15. Bertrand D., Galzi J.L., Devillers-Thiery A., Bertrand S., Changeux J.P. Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6971-6975.
16. Bertrand S., Weiland S., Berkovic S.F., Steinlein O.K., Bertrand D. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy. Br. J. Pharmacol. 125:1998;751-760.
17. Bickford-Wimer P.C., Nagamoto H., Johnson R., Adler L.E., Egan M., Rose G.M., Freedman R. Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol. Psychiatry. 27:1990;183-192.
18. Blandfort M., Tsuboi T., Vogel F. Genetic counseling in the epilepsies. I. Genetic risks. Hum. Genet. 76:1987;303-331.
19. Boulter J., O'Shea-Greenfield A., Duvoisin R.M., Connolly J.G., Wada E., Jensen A., Gardner P.D., Ballivet M., Deneris E.S., McKinnon D. et al. Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J. Biol. Chem. 265:1990;4472-4482.
20. 125I]-alpha-bungarotoxin binding in human postmortem brain. J. Comp. Neurol. 387:1997;385-398.
21. 3H]nicotine binding in human postmortem brain. J. Pharmacol. Exp. Ther. 282:1997;7-13.
22. Breese CRL, Lee MJ, Adams, CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S. Abnormal regulation of the high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 2000; in press.
23. Broide RS, Orr-Urtreger A, Dang H, Kasten MR, Dani JA, Beaudet AL, Patrick JW. Mice homozygous for the alpha7 L247T nicotinic acetylcholine receptor mutation show increased neuronal apoptosis and die within hours after birth. J Neurochem 2000; in press.
24. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Lane C.R., Lim E.P., Kalayanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22:1999;231-238.
25. Chini B., Raimond E., Elgoyhen A.B., Moralli D., Balzaretti M., Heinemann S. Molecular cloning and chromosomal localization of the human alpha 7- nicotinic receptor subunit gene (CHRNA7). Genomics. 19:1994;379-381.
26. Clarke P.B. Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation. Prog. Brain Res. 98:1993;77-83.
27. Clementz B.A., Geyer M.A., Braff D.L. Poor P50 suppression among schizophrenia patients and their first- degree biological relatives. Am. J. Psychiatry. 155:1998;1691-1694.
28. Clementz B.A., Grove W.M., Iacono W.G., Sweeney J.A. Smooth-pursuit eye movement dysfunction and liability for schizophrenia: implications for genetic modeling. J. Abnorm. Psychol. 101:1992;117-129.
29. Cloninger C.R. Turning point in the design of linkage studies of schizophrenia. Am. J. Med. Genet. 54:1994;83-92.
30. Conroy W.G., Berg D.K. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem. 270:1995;4424-4431.
31. Court J., Clementi F. Distribution of nicotinic subtypes in human brain. Alzheimer Dis. Assoc. Disord. 9:1995;6-14.
32. Crow T.J. Current status of linkage for schizophrenia: polygenes of vanishingly small effect or multiple false positives? Am. J. Med. Genet. 74:1997;99-103.
33. Curtis L., Blouin J.L., Radhakrishna U., Gehrig C., Lasseter V.K., Wolyniec P., Nestadt G., Dombroski B., Kazazian H.H., Pulver A.E., Housman D., Bertrand D., Antonarakis S.E. No evidence for linkage between schizophrenia and markers at chromosome 15q13-14. Am. J. Med. Genet. 88:1999;109-112.
34. 3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor. J. Biol. Chem. 265:1990;11017-11029.
35. Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., Heinemann S. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 79:1994;705-715.
36. Elliott K.J., Ellis S.B., Berckhan K.J., Urrutia A., Chavez-Noriega L.E., Johnson E.C., Velicelebi G., Harpold M.M. Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits. J. Mol. Neurosci. 7:1996;217-228.
37. Elmslie F.V., Rees M., Williamson M.P., Kerr M., Kjeldsen M.J., Pang K.A., Sundqvist A., Friis M.L., Chadwick D., Richens A., Covanis A., Santos M., Arzimanoglou A., Panayiotopoulos C.P., Curtis D., Whitehouse W.P., Gardiner R.M. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum. Mol. Genet. 6:1997;1329-1334.
38. Eng CMK, Kozak CA, Beaudet AL, Zoghbi HY. Mapping of multiple subunits of the neuronal nicotinic acetylcholine recptor to chromosome 15 in man and chromosome 9 in mouse. Genomics 1991;9:278-282.
39. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48:1997;649-684.
40. Falk C.T., Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51:1987;227-233.
41. Fieber L.A., Adams D.J. Acetylcholine-evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia. J. Physiol. (Lond.). 434:1991;215-237.
42. Fischer U., Reinhardt S., Albuquerque E.X., Maelicke A. Expression of functional alpha7 nicotinic acetylcholine receptor during mammalian muscle development and denervation. Eur. J. Neurosci. 11:1999;2856-2864. [In Process Citation].
43. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U.S.A. 94:1997;587-592.
44. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry. 38:1995;22-33.
45. Freedman R., Waldo M., Bickford-Wimer P., Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schizophr. Res. 4:1991;233-243.
46. Friedman L., Jesberger J.A., Meltzer H.Y. A model of smooth pursuit performance illustrates the relationship between gain, catch-up saccade rate, and catch-up saccade amplitude in normal controls and patients with schizophrenia. Biol. Psychiatry. 30:1991;537-556.
47. Fuchs P.A., Murrow B.W. A novel cholinergic receptor mediates inhibition of chick cochlear hair cells. Proc. R. Soc. Lond. B Biol. Sci. 248:1992;35-40.
48. Futami T., Takakusaki K., Kitai S.T. Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta. Neurosci. Res. 21:1995;331-342.
49. Gault J., Robinson M., Berger R., Drebing C., Logel J., Hopkins J., Moore T., Jacobs S., Meriwether J., Choi M.J., Kim E.J., Walton K., Buiting K., Davis A., Breese C., Freedman R., Leonard S. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics. 52:1998;173-185.
50. 3H]chlorpromazine labels homologous residues in the beta and delta chains. Biochemistry. 26:1987;2410-2418.
51. Goff D.C., Henderson D.C., Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry. 149:1992;1189-1194.
52. Goldman D., Deneris E., Luyten W., Kochhar A., Patrick J., Heinemann S. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell. 48:1987;965-973.
53. Gottesman I. Schizophrenia Genesis. The Origin of Madness. 1991;W.H. Freeman, New York.
54. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Prog. Neurobiol. 53:1997;199-237.
55. Grando S.A., Horton R.M., Mauro T.M., Kist D.A., Lee T.X., Dahl M.V. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J. Invest. Dermatol. 107:1996;412-418.
56. Guipponi M., Baldy-Moulinier M., Malafosse A. A fok1 polymorphism in the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene. Clin. Genet. 51:1997;78-79.
57. Hefft S., Hulo S., Bertrand D., Muller D. Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices. J. Physiol. (Lond.). 515:1999;769-776.
58. Hiemke C., Stolp M., Reuss S., Wevers A., Reinhardt S., Maelicke A., Schlegel S., Schroder H. Expression of alpha subunit genes of nicotinic acetylcholine receptors in human lymphocytes. Neurosci. Lett. 214:1996;171-174.
59. Hodge S.E. What association analysis can and cannot tell us about the genetics of complex disease. Am. J. Med. Genet. 54:1994;318-323.
60. Holzman P.S., Kringlen E., Matthysse S., Flanagan S.D., Lipton R.B., Cramer G., Levin S., Lange K., Levy D.L. A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch. Gen. Psychiatry. 45:1988;641-647. [see comments].
61. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry. 143:1986;993-997.
62. Iwata H., Hirose S., Akiyoshi H., Kaneko S., Mitsudome A. A novel intragenetic PvuII marker in the human neuronal nicotinic acetylcholine receptor a4 subunit gene (CHRNA4). Mutation and polymorphism report no. 62. Online. Hum. Mutat. 14:1999;93. [in process citation].
63. Kao P.N., Karlin A. Acetylcholine receptor binding site contains a disulfide cross-link between adjacent half-cystinyl residues. J. Biol. Chem. 261:1986;8085-8088.
64. Karlin A., Akabas M.H. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron. 15:1995;1231-1244.
65. Kaufmann C.A., Suarez B., Malaspina D., Pepple J., Svrakic D., Markel P.D., Meyer J., Zambuto C.T., Schmitt K., Matise T.C., Harkavy Friedman J.M., Hampe C., Lee H., Shore D., Wynne D., Faraone S.V., Tsuang M.T., Cloninger C.R. NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am. J. Med. Genet. 81:1998;282-289.
66. Koyama K., Sudo K., Nakamura Y. Mapping of the human nicotinic acetylcholine receptor beta 3 gene (CHRNB3) within chromosome 8p11.2. Genomics. 21:1994;460-461.
67. Kubalek E., Ralston S., Lindstrom J., Unwin N. Location of subunits within the acetylcholine receptor by electron image analysis of tubular crystals from Torpedo marmorata. J. Cell. Biol. 105:1987;9-18.
68. 2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J. Neurosci. 17:1997;9035-9047.
69. Lathrop G.M. Genetic approaches to common diseases. Curr. Opin. Biotechnol. 4:1993;678-683.
70. Le Novere N., Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 40:1995;155-172.
71. Lebargy F., Benhammou K., Morin D., Zini R., Urien S., Bree F., Bignon J., Branellec A., Lagrue G. Tobacco smoking induces expression of very-high-affinity nicotine binding sites on blood polymorphonuclear cells. Am. J. Respir. Crit. Care Med. 153:1996;1056-1063.
72. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J. Neurosci. 17:1997;576-585.
73. Lena C., Changeux J.P., Mulle C. Evidence for 'preterminal' nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13:1993;2680-2688.
74. Leonard S., Adler L.E., Olincy A., Breese C.R., Gault J., Ross R.G., Lee M., Cawthra E., Nagamoto H.T., Freedman R. The role of nicotine and nicotinic receptors in psychopathology. Arneric S.P., Brioni J.D. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. 1998;305-320 Wiley-Liss, New York.
75. Leonard S., Gault J., Moore T., Hopkins J., Robinson M., Olincy A., Adler L.E., Cloninger C.R., Kaufmann C.A., Tsuang M.T., Faraone S.V., Malaspina D., Svrakic D.M., Freedman R. Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative. Am. J. Med. Genet. 81:1998;308-312.
76. Liu Q.S., Berg D.K. Extracellular calcium regulates responses of both alpha3- and alpha7-containing nicotinic receptors on chick ciliary ganglion neurons. J. Neurophysiol. 82:1999;1124-1132.
77. Lueders K.K., Elliott R.W., Marenholz I., Mischke D., DuPree M., Hamer D. Genomic organization and mapping of the human and mouse neuronal beta2-nicotinic acetylcholine receptor genes. Mamm. Genome. 10:1999;900-905. [in process citation].
78. Luntz-Leybman V., Bickford P.C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
79. Magnusson A., Nakken K.O., Brubakk E. Autosomal dominant frontal epilepsy. Lancet. 347:1996;1191-1192. [letter; comment].
80. McCormick D.A., Prince D.A. Actions of acetylcholine in the guinea-pig and cat medial and lateral geniculate nuclei, in vitro. J. Physiol. (Lond.). 392:1987;147-165.
81. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
82. McGue M., Gottesman I.I. Genetic linkage in schizophrenia: perspectives from genetic epidemiology. Schizophr. Bull. 15:1989;453-464.
83. Meierkord H. Epilepsy and sleep. Curr. Opin. Neurol. 7:1994;107-112.
84. Mihovilovic M., Hulette C., Mittelstaedt J., Austin C., Roses A.D. Nicotinic neuronal acetylcholine receptor alpha-3 subunit transcription in normal and myasthenic thymus. Ann. N. Y. Acad. Sci. 681:1993;83-96.
85. Mishina M., Tobimatsu T., Imoto K., Tanaka K., Fujita Y., Fukuda K., Kurasaki M., Takahashi H., Morimoto Y., Hirose T. et al. Location of functional regions of acetylcholine receptor alpha-subunit by site-directed mutagenesis. Nature. 313:1985;364-369.
86. Miyazawa A., Fujiyoshi Y., Stowell M., Unwin N. Nicotinic acetylcholine receptor at 4.6 A resolution: transverse tunnels in the channel wall. J. Mol. Biol. 288:1999;765-786.
87. Neubauer B.A., Fiedler B., Himmelein B., Kampfer F., Lassker U., Schwabe G., Spanier I., Tams D., Bretscher C., Moldenhauer K., Kurlemann G., Weise S., Tedroff K., Eeg-Olofsson O., Wadelius C., Stephani U. Centrotemporal spikes in families with rolandic epilepsy: linkage to chromosome 15q14. Neurology. 51:1998;1608-1612.
88. Olincy A., Ross R.G., Young D.A., Roath M., Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology. 18:1998;175-185.
89. Ott J. Analysis of Human Genetic Linkage. 1991;The John Hopkins University Press, Baltimore, MD.
90. Parkinson D., Kratz K.E., Daw N.W. Evidence for a nicotinic component to the actions of acetylcholine in cat visual cortex. Exp. Brain Res. 73:1988;553-568.
91. Phillips H.A., Mulley J.C. SSCP variants within the alpha 4 subunit of the neuronal nicotinic acetylcholine receptor gene. Clin. Genet. 51:1997;135-136.
92. Phillips H.A., Scheffer I.E., Berkovic S.F., Hollway G.E., Sutherland G.R., Mulley J.C. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat. Genet. 10:1995;117-118. [letter, see comments].
93. Phillips H.A., Scheffer I.E., Crossland K.M., Bhatia K.P., Fish D.R., Marsden C.D., Howell S.J., Stephenson J.B., Tolmie J., Plazzi G., Eeg-Olofsson O., Singh R., Lopes-Cendes I., Andermann E., Andermann F., Berkovic S.F., Mulley J.C. Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am. J. Hum. Genet. 63:1998;1108-1116.
94. Picciotto M.R., Zoli M., Zachariou V., Changeux J.P. Contribution of nicotinic acetylcholine receptors containing the beta 2- subunit to the behavioural effects of nicotine. Biochem. Soc. Trans. 25:1997;824-829.
95. Radant A.D., Hommer D.W. A quantitative analysis of saccades and smooth pursuit during visual pursuit tracking. A comparison of schizophrenics with normals and substance abusing controls. Schizophr. Res. 6:1992;225-235.
96. Raimondi E., Rubboli F., Moralli D., Chini B., Fornasari D., Tarroni P., De Carli L., Clementi F. Chromosomal localization and physical linkage of the genes encoding the human alpha 3, alpha 5, and beta 4 neuronal nicotinic receptor subunits. Genomics. 12:1992;849-850.
97. Ramirez-Latorre J., Yu C.R., Qu X., Perin F., Karlin A., Role L. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature. 380:1996;347-351.
98. Rempel N., Heyers S., Engels H., Sleegers E., Steinlein O.K. The structures of the human neuronal nicotinic acetylcholine receptor beta2- and alpha3-subunit genes (CHRNB2 and CHRNA3). Hum. Genet. 103:1998;645-653.
99. Revah F., Bertrand D., Galzi J.L., Devillers-Thiery A., Mulle C., Hussy N., Bertrand S., Ballivet M., Changeux J.P. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature. 353:1991;846-849.
100. Riley BPM-C, Jenkins RJ, Williamson R, Collier DA, Murray RM. Further suggestive evidence for involvement of the a7-nicotinic cholinergic receptor gene on chromosome 15q13-14 in schizophrenia. Am J Hum Genet 1997;61.
101. Risch N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet. Epidemiol. 7:1990;3-16.
102. Risch N. Developments in gene mapping with linkage methods. Curr. Opin. Genet. Dev. 1:1991;93-98.
103. Risch N., Merikangas K.R. Linkage studies of psychiatric disorders. Eur. Arch. Psychiatry Clin. Neurosci. 243:1993;143-149.
104. Role L.W. Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr. Opin. Neurobiol. 2:1992;254-262.
105. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
106. Rollins YDS, KE, Harris KR, Hall ME, Rose GM, Leonard S. Reduction in auditory gating following intracerebroventricular application of a-bungarotoxin binding site ligands and a7 antisense oligonucleotides. Soc Neurosci Abstr 1993;19.
107. Rubboli F., Court J.A., Sala C., Morris C., Perry E., Clementi F. Distribution of neuronal nicotinic receptor subunits in human brain. Neurochem. Int. 25:1994;69-71.
108. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
109. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., Fish D.R., Marsden C.D., Andermann E., Andermann F., Desbiens R., Keene D., Cendes F. et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain. 118:1995;61-73.
110. Schroder H., de Vos R.A., Jansen E.N., Birtsch C., Wevers A., Lobron C., Nowacki S., Schroder R., Maelicke A. Gene expression of the nicotinic acetylcholine receptor alpha 4 subunit in the frontal cortex in Parkinson's disease patients. Neurosci. Lett. 187:1995;173-176.
111. Searl T.J., Redman R.S., Silinsky E.M. Mutual occlusion of P2X ATP receptors and nicotinic receptors on sympathetic neurons of the guinea-pig. J. Physiol. (Lond.). 510:1998;783-791.
112. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13:1993;596-604.
113. Seifert R., Scholten A., Gauss R., Mincheva A., Lichter P., Kaupp U.B. Molecular characterization of a slowly gating human hyperpolarization-activated channel predominantly expressed in thalamus, heart, and testis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9391-9396.
114. Sivilotti L., Colquhoun D. Acetylcholine receptors: too many channels, too few functions. Science. 269:1995;1681-1682. [see comments].
115. Snead O.C. III Basic mechanisms of generalized absence seizures. Ann. Neurol. 37:1995;146-157.
116. Steinlein O., Sander T., Stoodt J., Kretz R., Janz D., Propping P. Possible association of a silent polymorphism in the neuronal nicotinic acetylcholine receptor subunit alpha4 with common idiopathic generalized epilepsies. Am. J. Med. Genet. 74:1997;445-449.
117. Steinlein O., Smigrodzki R., Lindstrom J., Anand R., Kohler M., Tocharoentanaphol C., Vogel F. Refinement of the localization of the gene for neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) to human chromosome 20q13.2-q13.3. Genomics. 22:1994;493-495.
118. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet. 6:1997;943-947.
119. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., Berkovic S.F. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11:1995;201-203.
120. Steriade M., McCormick D.A., Sejnowski T.J. Thalamocortical oscillations in the sleeping and aroused brain. Science. 262:1993;679-685.
121. Summers K.L., Giacobini E. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem. Res. 20:1995;753-759.
122. Swanson K.L., Albuquerque E.X. Nicotinic acetylcholine receptor ion channel blockade by cocaine: the mechanism of synaptic action. J. Pharmacol. Exp. Ther. 243:1987;1202-1210.
123. Szymusiak R. Magnocellular nuclei of the basal forebrain: substrates of sleep and arousal regulation. Sleep. 18:1995;478-500.
124. Tohgi H., Utsugisawa K., Yoshimura M., Nagane Y., Mihara M. Age-related changes in nicotinic acetylcholine receptor subunits alpha4 and beta2 messenger RNA expression in postmortem human frontal cortex and hippocampus. Neurosci. Lett. 245:1998;139-142.
125. Tsuang M.T., Faraone S.V. The genetic epidemiology of schizophrenia. Compr. Ther. 20:1994;130-135.
126. Vernino S., Amador M., Luetje C.W., Patrick J., Dani J.A. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron. 8:1992;127-134.
127. Vidal C., Changeux J.P. Pharmacological profile of nicotinic acetylcholine receptors in the rat prefrontal cortex: an electrophysiological study in a slice preparation. Neuroscience. 29:1989;261-270.
128. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
129. Weiland S., Steinlein O. Dinucleotide polymorphism in the first intron of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4). Clin. Genet. 50:1996;433-434.
130. Weiland S., Witzemann V., Villarroel A., Propping P., Steinlein O. An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett. 398:1996;91-96.
131. Wenner P., O'Donovan M.J. Identification of an interneuronal population that mediates recurrent inhibition of motoneurons in the developing chick spinal cord. J. Neurosci. 19:1999;7557-7567. [in process citation].
132. Wessler I., Kirkpatrick C.J., Racke K. The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin. Exp. Pharmacol. Physiol. 26:1999;198-205.
133. Whiting P.J., Schoepfer R., Conroy W.G., Gore M.J., Keyser K.T., Shimasaki S., Esch F., Lindstrom J.M. Expression of nicotinic acetylcholine receptor subtypes in brain and retina. Brain Res. Mol. Brain Res. 10:1991;61-70.
134. Williamson P.D. Frontal lobe epilepsy: some clinical characteristics. Jasper H.H., Riggio S., Goldman-Rakic P.S. Advances in Neurology: Epilepsy and the Functional Anatomy of the Frontal Lobe. 1995;127-152 Raven Press, New York.
135. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
136. Wood S., Schertzer M., Yaremko M.L. Identification of the human neuronal nicotinic cholinergic alpha 2 receptor locus, (CHRNA2), within an 8p21 mapped locus, by sequence homology with rat DNA. Somat. Cell Mol. Genet. 21:1995;147-150.
137. Zara F., Bianchi A., Avanzini G., Di Donato S., Castellotti B., Patel P.I., Pandolfo M. Mapping of genes predisposing to idiopathic generalized epilepsy. Hum. Mol. Genet. 4:1995;1201-1207.
138. Zhang M., Wang Y.T., Vyas D.M., Neuman R.S., Bieger D. Nicotinic cholinoceptor-mediated excitatory postsynaptic potentials in rat nucleus ambiguus. Exp. Brain Res. 96:1993;83-88.
139. Zhou X., Galligan J.J. Non-additive interaction between nicotinic cholinergic and P2X purine receptors in guinea-pig enteric neurons in culture. J. Physiol. (Lond.). 513:1998;685-697. [see comments].